Suppr超能文献

Prostaglandin inhibition and cardiovascular risk: maybe timing really is everything.

作者信息

Bertagnolli Monica M, Zauber Ann G, Solomon Scott

机构信息

Dana-Farber/Brigham and Women's Cancer Center, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA.

出版信息

Cancer Prev Res (Phila). 2009 Mar;2(3):195-6. doi: 10.1158/1940-6207.CAPR-08-0245. Epub 2009 Mar 3.

Abstract
摘要

相似文献

2
Cardiovascular risks of cyclooxygenase inhibition.环氧化酶抑制的心血管风险。
Pharmacotherapy. 2006 Jul;26(7):919-38. doi: 10.1592/phco.26.7.919.
5
Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
J Natl Cancer Inst. 2005 Apr 20;97(8):552-3. doi: 10.1093/jnci/97.8.552.
7
Cyclooxygenase-2 inhibitors: what went wrong?环氧化酶-2抑制剂:出了什么问题?
Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):89-94. doi: 10.1097/01.mco.0000214565.67439.83.
8
[Primary dysmenorrhea and prostaglandins].
Duodecim. 1978;94(16):958-60.
9
Renal consequences of prostaglandin inhibition in heart failure.
Heart Fail Clin. 2008 Oct;4(4):505-10. doi: 10.1016/j.hfc.2008.03.002.

引用本文的文献

1
Aspirin and familial adenomatous polyposis: coming full circle.阿司匹林与家族性腺瘤性息肉病:兜兜转转。
Cancer Prev Res (Phila). 2011 May;4(5):623-7. doi: 10.1158/1940-6207.CAPR-11-0157.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验